Key facts
- It has raised $3.0M; the latest was Seed Round ($3.0M) in May 2025.
- Notable investors include VP Venture Partners, Wlanholding, eQventure.
- Status: Privately Held (backing).
Investors
3- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for aTENSION.life
- ·The full record, as it builds
Funding rounds
No funding rounds for aTENSION.life are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About aTENSION.life
Operator of a biotechnology company intended to offer hypertension care. The company's platform offers precision diagnostics and personalized therapies and provides underlying causes of uncontrolled blood pressure that can be obtained from just one blood sample, enabling patients to help with hypertension diagnostics.
- Sector
- Healthcare
- HQ
- Vienna, Austria
- Founded
- 2024
- Website
- atension.life/
- Ownership
- Privately Held (backing)
aTENSION.life doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in aTENSION.life shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on aTENSION.life in its N-PORT filings yet. We sweep new filings monthly.